No title
Cutaneous malignant melanoma (CMM) is one of the most aggressive skin malignancies with poor prognosisfor the patients with metastatic disease. Earlier studies have highlighted the existing molecular diversityamongst CMM tumors. Such diversity does not result from the malignant cells alone but a product of multitudeof complex interactions among the melanoma and non-melanoma cells in the tumor micr
